Tacrolimus therapy in pediatric patients with treatment-resistant nephrotic syndrome (Q44752973)

6 December 2017

Tacrolimus therapy in pediatric patients with treatment-resistant nephrotic syndrome (English)

1 reference

6 December 2017

Kim Loeffler

1

1 reference

PubMed ID

14758528

6 December 2017

Manjula Gowrishankar

series ordinal

2

1 reference

PubMed ID

14758528

6 December 2017

Verna Yiu

series ordinal

3

1 reference

6 December 2017

3 February 2004

1 reference

6 December 2017

1 reference

6 December 2017

19

1 reference

6 December 2017

3

1 reference

6 December 2017

281-287

1 reference

https://scigraph.springernature.com/pub.10.1007/s00467-003-1370-3

6 December 2017

0 references

cites work

Primary focal segmental glomerulosclerosis in children: prognostic factors

1 reference

12 December 2020

Renal transplantation in children and adolescents: the 1992 annual report of the North American Pediatric Renal Transplant Cooperative Study.

1 reference

12 December 2020

Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis. A report of the International Study of Kidney Disease in Children.

1 reference

12 December 2020

Treatment of FSGS with plasma exchange and immunadsorption.

1 reference

12 December 2020

Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Con

1 reference

12 December 2020

Renal transplantation, chronic dialysis, and chronic renal insufficiency in children and adolescents. The 1995 Annual Report of the North American Pediatric Renal Transplant Cooperative Study.

1 reference

12 December 2020

Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome

1 reference

12 December 2020

The long-term prognosis of patients with focal segmental glomerulosclerosis

1 reference

12 December 2020

Evaluation and management of proteinuria and nephrotic syndrome in children: recommendations from a pediatric nephrology panel established at the National Kidney Foundation conference on proteinuria, albuminuria, risk, assessment, detection, and eli

1 reference

12 December 2020

Differing proteinuria control with cyclosporin and tacrolimus

1 reference

12 December 2020

Primary focal segmental glomerulosclerosis: clinical course and response to therapy

1 reference

12 December 2020

Combined therapy of tacrolimus and corticosteroids in cyclosporin-resistant or -dependent idiopathic focal glomerulosclerosis: a preliminary uncontrolled study with prospective follow-up

1 reference

12 December 2020

A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine

1 reference

12 December 2020

Adding plasmapheresis to corticosteroids and alkylating agents: does it benefit patients with focal segmental glomerulosclerosis?

1 reference

12 December 2020

Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndrome

1 reference

12 December 2020

Tacrolimus treatment for steroid- and cyclosporin-resistant minimal-change nephrotic syndrome

1 reference

12 December 2020

Therapy of focal and segmental glomerulosclerosis with methylprednisolone, cyclosporine A, and prednisone

1 reference

12 December 2020

Response to cyclophosphamide in steroid-resistant focal segmental glomerulosclerosis: a reappraisal

1 reference

12 December 2020

Steroid-resistant nephrotic focal segmental glomerulosclerosis: a treatable disease

1 reference

12 December 2020

Inhibition of vascular permeability factor production by ciclosporin in minimal change nephrotic syndrome

1 reference

12 December 2020

Aggressive treatment of severe idiopathic focal segmental glomerulosclerosis

1 reference

12 December 2020

Therapy of focal segmental glomerulosclerosis with cyclosporine A

1 reference

12 December 2020

The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative retrospective study

1 reference

12 December 2020

Plasma immunadsorption treatment in patients with primary focal and segmental glomerulosclerosis

1 reference

12 December 2020

Management of focal segmental glomerulosclerosis: evidence-based recommendations.

1 reference

12 December 2020

Pilot trial of FK 506 in the management of steroid-resistant nephrotic syndrome

1 reference

12 December 2020

FK 506 for vascular permeability factor production in minimal change nephrotic syndrome

1 reference

12 December 2020

High incidence of focal segmental glomerulosclerosis in nephrotic syndrome of childhood

1 reference

12 December 2020

Immunosuppressive strategies in transplantation

1 reference

12 December 2020

A renal allograft recipient with late recurrence of focal and segmental glomerulosclerosis after switching from cyclosporine to tacrolimus.

1 reference

12 December 2020

Focal glomerulosclerosis: natural history and treatment. A report of 70 cases.

1 reference

12 December 2020

Focal segmental glomerulosclerosis in children with idiopathic nephrotic syndrome. A report of the Southwest Pediatric Nephrology Study Group

1 reference

12 December 2020

Effective tacrolimus treatment in a child suffering from severe nephrotic syndrome

1 reference

12 December 2020

FK 506 in steroid-resistant focal sclerosing glomerulonephritis of childhood.

1 reference

12 December 2020

One-center experience with cyclosporine in refractory nephrotic syndrome in children

1 reference

12 December 2020

Focal segmental glomerulosclerosis with idiopathic nephrotic syndrome: three types of clinical response

1 reference

12 December 2020

10.1007/S00467-003-1370-3

Identifiers

DOI

1 reference

6 December 2017

1 reference

PubMed ID

14758528